MENTAL RETARDATION, AUTOSOMAL DOMINANT 33
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Loss-of-function variation in the DPP6 gene is associated with autosomal dominant microcephaly and mental retardation.
|
23832105 |
2013 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 33
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Loss-of-function variation in the DPP6 gene is associated with autosomal dominant microcephaly and mental retardation.
|
23832105 |
2013 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 33
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MENTAL RETARDATION, AUTOSOMAL DOMINANT 33
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Amyotrophic Lateral Sclerosis
|
0.470 |
AlteredExpression
|
disease |
BEFREE |
C9-ALS motor neurons showed altered expression of genes involved in membrane excitability including DPP6, and demonstrated a diminished capacity to fire continuous spikes upon depolarization compared to control motor neurons.
|
24154603 |
2013 |
Amyotrophic Lateral Sclerosis
|
0.470 |
GeneticVariation
|
disease |
BEFREE |
Two SNPs located in genes that were implicated by previous GWA studies of ALS were marginally significant in the pooled analysis of discovery and replication samples: rs17174381 in DPP6 (p = 4.4×10(-4)) and rs6985069 near ELP3 (p = 4.8×10(-4)).
|
22470424 |
2012 |
Amyotrophic Lateral Sclerosis
|
0.470 |
Biomarker
|
disease |
BEFREE |
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population.
|
19525032 |
2011 |
Amyotrophic Lateral Sclerosis
|
0.470 |
Biomarker
|
disease |
BEFREE |
Analysis of DPP6 and FGGY as candidate genes for amyotrophic lateral sclerosis.
|
20001489 |
2010 |
Amyotrophic Lateral Sclerosis
|
0.470 |
GeneticVariation
|
disease |
BEFREE |
In our association analyses, we identified two loci that met our criteria for follow-up: the DPP6 locus (OR = 3.59, P = 6.6 × 10(-3)), which has already been implicated in ALS pathogenesis, and the 15q11.2 locus, containing NIPA1 (OR = 12.46, P = 9.3 × 10(-5)), the gene causing hereditary spastic paraparesis type 6 (HSP 6).
|
20685689 |
2010 |
Amyotrophic Lateral Sclerosis
|
0.470 |
Biomarker
|
disease |
BEFREE |
Indeed, the three loci (FGGY, ITPR2 and DPP6) identified in previous GWAS of sporadic ALS were not significantly associated with disease in our study.
|
19193627 |
2009 |
Amyotrophic Lateral Sclerosis
|
0.470 |
GeneticVariation
|
disease |
GWASDB |
We identified a SNP in the DPP6 gene that is consistently strongly associated with susceptibility to amyotrophic lateral sclerosis (ALS) in different populations of European ancestry, with an overall P value of 5.04 x 10(-8) in 1,767 cases and 1,916 healthy controls and with an odds ratio of 1.30 (95% confidence interval (CI) of 1.18-1.43).
|
18084291 |
2008 |
Amyotrophic Lateral Sclerosis
|
0.470 |
GeneticVariation
|
disease |
LHGDN |
We identified a SNP in the DPP6 gene that is consistently strongly associated with susceptibility to amyotrophic lateral sclerosis (ALS) in different populations of European ancestry, with an overall P value of 5.04 x 10(-8) in 1,767 cases and 1,916 healthy controls and with an odds ratio of 1.30 (95% confidence interval (CI) of 1.18-1.43).
|
18084291 |
2008 |
Amyotrophic Lateral Sclerosis
|
0.470 |
GeneticVariation
|
disease |
GWASCAT |
We identified a SNP in the DPP6 gene that is consistently strongly associated with susceptibility to amyotrophic lateral sclerosis (ALS) in different populations of European ancestry, with an overall P value of 5.04 x 10(-8) in 1,767 cases and 1,916 healthy controls and with an odds ratio of 1.30 (95% confidence interval (CI) of 1.18-1.43).
|
18084291 |
2008 |
Amyotrophic Lateral Sclerosis
|
0.470 |
GeneticVariation
|
disease |
BEFREE |
Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis.
|
18084291 |
2008 |
Amyotrophic Lateral Sclerosis
|
0.470 |
Biomarker
|
disease |
CTD_human |
We identified a SNP in the DPP6 gene that is consistently strongly associated with susceptibility to amyotrophic lateral sclerosis (ALS) in different populations of European ancestry, with an overall P value of 5.04 x 10(-8) in 1,767 cases and 1,916 healthy controls and with an odds ratio of 1.30 (95% confidence interval (CI) of 1.18-1.43).
|
18084291 |
2008 |
Paroxysmal familial ventricular fibrillation
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Previous studies demonstrated that variants in dipeptidyl aminopeptidase-like protein-6 (DPP6) are involved in idiopathic ventricular fibrillation.
|
31476289 |
2019 |
Paroxysmal familial ventricular fibrillation
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation of dipeptidyl aminopeptidase-like protein-6 in a family with suspicious idiopathic ventricular fibrillation.
|
29474731 |
2018 |
Paroxysmal familial ventricular fibrillation
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
We collected mortality data from mutation-positive subjects with either DPP6-associated idiopathic ventricular fibrillation, SCN5A overlap syndrome, and PLN-R14del-mediated arrhythmogenic cardiomyopathy >2 to 10 years of ongoing clinical/cascade genetic screening.
|
30354299 |
2018 |
Paroxysmal familial ventricular fibrillation
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Detailed characterization of familial idiopathic ventricular fibrillation linked to the DPP6 locus.
|
26681609 |
2016 |
Paroxysmal familial ventricular fibrillation
|
0.360 |
Biomarker
|
disease |
BEFREE |
These results point to a previously unknown central role of DPP6 in PF I(to), with DPP6 gain of function selectively enhancing PF current, and suggest that a DPP6-mediated PF early-repolarization syndrome might be a novel molecular paradigm for some forms of idiopathic ventricular fibrillation.
|
23532596 |
2013 |
Paroxysmal familial ventricular fibrillation
|
0.360 |
Biomarker
|
disease |
BEFREE |
Haplotype-sharing analysis implicates chromosome 7q36 harboring DPP6 in familial idiopathic ventricular fibrillation.
|
19285295 |
2009 |
Paroxysmal familial ventricular fibrillation
|
0.360 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autism Spectrum Disorders
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
In addition, further genetic factors might be involved in the ASD pathogenesis of the patient including a missense DPP6 mutation (Arg322Cys), which segregated with the autistic phenotype within the family.
|
27651234 |
2016 |
Autism Spectrum Disorders
|
0.350 |
Biomarker
|
disease |
BEFREE |
Moreover, the DPP6 gene has been implicated in the pathogenesis of autism spectrum disorder (ASD) and, notably, in haloperidol-induced dyskinesia.
|
25129042 |
2014 |
Autism Spectrum Disorders
|
0.350 |
Biomarker
|
disease |
BEFREE |
Several others disrupt genes that have previously been implicated in autism, such as BDNF, AUTS2, DPP6, and C18orf22, and our data add to the growing evidence of their involvement in ASD.
|
24643514 |
2014 |